About Ray Otero-Alonso

This author has not yet filled in any details.
So far Ray Otero-Alonso has created 11 blog entries.

DP Clinical President and CEO selected as Fellow of the American Spinal Injury Association

ROCKVILLE, MD – October 10, 2023 – Devinder Poonian, President and CEO of DP Clinical, has been selected as a Fellow of the American Spinal Injury Association (FASIA) in recognition of distinguished accomplishments within the fields of spinal cord injury research, clinical practice, education, and advocacy, and for a longstanding membership of service to the [...]

2024-01-08T16:35:24+00:00

DP Clinical Congratulates NervGen Pharma on its First Subject Dosed in Spinal Cord Injury Clinical Trial

ROCKVILLE, MD – October 3, 2023 – DP Clinical congratulates NervGen Pharma Corp., a biotech company dedicated to developing innovative solutions for the treatment of nervous system damage, on dosing its first subject in the Company’s landmark Phase 1b/2a clinical trial for its proprietary lead compound, NVG-291, in individuals with spinal cord injury (SCI). Read more at [...]

2023-10-03T18:55:55+00:00

DP Clinical Congratulates MediWound on the US Commercialization of NexoBrid® for the Treatment of Severe Thermal Burns

ROCKVILLE, MD - September 28, 2023 - MediWound Ltd., an Israeli biopharmaceutical company, announced the US commercial availability of NexoBrid® in adults with severe thermal burns – a first step in the product becoming the new standard of care for eschar removal. MediWound has partnered with DP Clinical, a full-service CRO located in Rockville, Maryland, [...]

2023-09-28T14:47:31+00:00

DP Clinical Recognized by Canada’s Strategic Science Fund

ROCKVILLE, MD – October 26, 2022 – James (Jim) Hamer, Director, Spinal Cord Injury (SCI) Programs was recently recognized by the Canadian Government for his work with the Strategic Science Fund (SSF).  Jim served as a Technical Reviewer for the country's new SSF program.  This program was implemented to improve the effectiveness of federal investments used to [...]

2023-01-24T20:08:57+00:00

Jim Hamer Elected to Unite 2 Fight Paralysis (U2FP) Board of Directors

ROCKVILLE, MD – February 16, 2021 – DP Clinical, Inc., a Contract Research Organization (CRO) located in Rockville, Maryland, announces James (Jim) Hamer, Director, Spinal Cord Injury (SCI) Programs, at DP Clinical has been elected to the Board of Directors for Unite 2 Fight Paralysis (U2FP) organization and will serve a three-year term. U2FP’s mission [...]

2021-02-19T15:38:57+00:00

NEWS RELEASE: DP Clinical-Supported Study Results in FDA Approval of ADMA Biologics’ ASCENIV™

ROCKVILLE, MD – September 18, 2019 – DP Clinical, Inc., a Contract Research Organization (CRO) specializing in infectious disease, neuroscience, oncology, and ophthalmology Phase I-III clinical programs; congratulates ADMA Biologics’ on the approval of ASCENIV™ (immune globulin intravenous, human – slra 10% liquid). DP Clinical provided a full complement of CRO services for ADMA Biologics [...]

2019-09-18T16:30:22+00:00

PRESS RELEASE: DP Clinical Puts Its Confidence in Comprehend for Strategic Shift

REDWOOD CITY, Calif., Aug. 12, 2019 /PRNewswire/ -- DP Clinical, Inc. and Comprehend Systems, Inc. are joining forces to transition the Rockville, Maryland-based CRO from spreadsheets and EDC reports to a system that aligns study teams with visual data analytics, automated KRI monitoring with alerts, and fully-auditable task management workflow. Click here to read more.

2019-08-13T21:23:45+00:00
Go to Top